Prospective Study of Intravesical Dimethyl Sulphoxide in the Treatment of Chronic Inflammatory Bladder Disease
- 1 February 1987
- journal article
- research article
- Published by Wiley in British Journal of Urology
- Vol. 59 (2) , 142-144
- https://doi.org/10.1111/j.1464-410x.1987.tb04805.x
Abstract
Thirty patients with biopsy-proven chronic inflammatory bladder disease were treated with intravesical dimethyl sulphoxide (DMSO). Satisfactory symptomatic relief was achieved in 80% of patients completing treatment and no significant side effects were encountered. Despite the improvement in symptoms there was no sigificant alteration in the endoscopic or morphological appearance of the bladder after treatment. Intravesical DMSO is safe and relatively easy to administer and seems to have a place in the management of patients with this difficult problem.This publication has 7 references indexed in Scilit:
- Prospective study of intravesical dimethyl sulfoxide in treatment of suspected early interstitial cystitisUrology, 1981
- Dimethyl sulfoxide in treatment of inflammatory genitourinary disordersUrology, 1978
- The Use of Dimethyl-Sulfoxide (DMSO) in the Treatment of Interstitial CystitisScandinavian Journal of Urology and Nephrology, 1978
- Further Experience with Intravesical Dimethyl Sulfoxide in the Treatment of Interstitial CystitisJournal of Urology, 1976
- The Treatment of Patients with Interstitial Cystitis, with Special Reference to Intravesical DMSOJournal of Urology, 1972
- THE METABOLISM OF DIMETHYL SULFOXIDE AND ITS METABOLIC EFFECTS IN MAN AND ANIMALSAnnals of the New York Academy of Sciences, 1967
- SUMMARY OF THE NEW YORK ACADEMY OF SCIENCES SYMPOSIUM ON THE "BIOLOGICAL ACTIONS OF DIMETHYL SULFOXIDE"Annals of the New York Academy of Sciences, 1967